Wei Hua, Wang Jiali, Liang Zhaozhi
Nephrology Department, Xinxiang Central Hospital, Xinxiang, China.
Ann Transl Med. 2020 Aug;8(16):1002. doi: 10.21037/atm-20-5167.
Chronic nephrosis (CN) is an aging-related disease with high mortality. Signal transduction and transcriptional activator 1 (STAT1) protein promotes senescence in human glomerular mesangial cells (HMCs), but whether it affects the progression of adriamycin (ADR)-induced CN remains unclear.
We established an ADR-induced CN mouse model that was completed in wild-type (wt) mice by a single intravenous injection of 10 mg/kg ADR for 2 or 4 weeks. Clinical indexes in each group were determined. Hematoxylin and eosin staining (H&E) was employed to determine renal histopathological damage, SA-β-gal staining was used to evaluate cell senescence phenotype. TUNEL and immunohistochemistry (IHC) staining were used to detect renal apoptosis. Protein levels of Bcl-2, Bax, STAT1, p53 and p21 were measured by Western Blot.
STAT1 intervention ameliorated renal function. H&E staining indicated that STAT1-deficient ( ) improved the renal tubular injury, and obviously inhibited the apoptosis and Caspase-3 number in kidney tissues. Besides, decreased proteinuria, and the levels of urea nitrogen and creatinine as well as that of reactive oxygen species induced by ADR. Also, resulted in the reduced expression of p53 and p21.
Our current study strongly demonstrated the involvement of the STAT1-p53-p21 axis in the regulation of CN and is a potential target for the nephrosis treatment.
慢性肾病(CN)是一种与衰老相关的疾病,死亡率很高。信号转导和转录激活因子1(STAT1)蛋白可促进人肾小球系膜细胞(HMCs)衰老,但它是否影响阿霉素(ADR)诱导的CN进展尚不清楚。
我们建立了ADR诱导的CN小鼠模型,通过对野生型(wt)小鼠单次静脉注射10 mg/kg ADR,持续2或4周来完成。测定每组的临床指标。采用苏木精-伊红染色(H&E)确定肾脏组织病理学损伤,用SA-β-半乳糖苷酶染色评估细胞衰老表型。采用TUNEL和免疫组织化学(IHC)染色检测肾脏细胞凋亡。通过蛋白质免疫印迹法检测Bcl-2、Bax、STAT1、p53和p21的蛋白水平。
STAT1干预改善了肾功能。H&E染色表明,STAT1缺陷型( )改善了肾小管损伤,并且明显抑制了肾组织中的细胞凋亡和Caspase-3数量。此外, 降低了蛋白尿、尿素氮和肌酐水平以及ADR诱导的活性氧水平。同时, 导致p53和p21表达降低。
我们目前的研究有力地证明了STAT1-p53-p21轴参与了CN的调控,是肾病治疗的一个潜在靶点。